Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|19|3555-3562

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.19, 2013-10, pp. : 3555-3562

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IRP1-independent alterations of cardiac iron metabolism in doxorubicin-treated mice

By Corna Gianfranca   Galy Bruno   Hentze Matthias   Cairo Gaetano  

Journal of Molecular Medicine, Vol. 84, Iss. 7, 2006-07 ,pp. : 551-560

Springer Publishing Company

Access to resources Recommend Favorite

Osteochondroma in long‐term survivors of high‐risk neuroblastoma

By  

CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. : 2090-2096

John Wiley & Sons Inc

Access to resources Recommend Favorite

High Incidence of Hemochromatosis Gene Mutations in the Myelodysplastic Syndrome: The Budapest Study on 50 Patients

By  

Acta Haematologica, Vol. 109, Iss. 2, 2003-03 ,pp. : 64-67

Karger

Access to resources Recommend Favorite

Prevalence of Hemochromatosis Gene (HFE) Mutations in Greece

By  

Acta Haematologica, Vol. 109, Iss. 3, 2003-05 ,pp. : 137-140

Karger

Access to resources Recommend Favorite

Analysis of KRAS and NRAS Gene Mutations in Arab Asian Children With Acute Leukemia: High Frequency of RAS Mutations in Acute Lymphoblastic Leukemia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 12, 2015-12 ,pp. : 2157-2161

John Wiley & Sons Inc

Access to resources Recommend Favorite